BioHealth News Archive
Annapolis medical device firm raises $1.5 million seed round – Baltimore Business Journal
An Annapolis firm focused on building medical devices to monitor heart disease has raised $1.5 million to help bring its first product to market.…
Read More
GSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosus | Antibodies | News Channels
GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of…
Read More
Leadership and strategic innovation in pharma | McKinsey & Company
Since 2013, Shire has been stepping up its strategy to become the world’s leading company for people with rare diseases. McKinsey senior partners Martin…
Read More
Elon Musk says he has a green light to build a NY–Philly–Baltimore–DC hyperloop – The Verge
Elon Musk just tweeted that his Boring Company tunnel project has received “verbal [government] approval” to build a hyperloop connecting New York City, Philadelphia,…
Read More
UNIV OF MARYLAND WebEx Enterprise Site
Master of Professional Studies in Technology Entrepreneurship The University of Maryland’s Master of Professional Studies (MPS) in Technology Entrepreneurship educates and empowers students to…
Read More
How UM Ventures helped a biotech startup get acquired in 18 months – Technical.ly Baltimore
A startup that spun out of research at the University of Maryland School of Medicine was acquired 18 months after forming. In a deal…
Read More
VLP Therapeutics Appoints Jacob Licht as Chief Operating Officer
VLP Therapeutics, LLC ("VLP"), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced the…
Read More
Europe has untapped medical innovation – but needs high speed connections to make it work
Richard Mason is head of J&J Innovation for the EMEA region, and identifying and investing in the most promising early-stage drug ideas outside the company…
Read More
Are you a US cyber, defense or security technology company looking to expand in the European market?
The Maryland Department of Commerce has an opportunity for you to soft land in the Hague Security Delta (HSD) — the largest security cluster…
Read More
Save the Date: Fewer Than 3 Months Until the 2017 American Small Business Cybersecurity Xchange Conference
The 2017 American Small Business Cybersecurity Xchange on October 12th will bring together cybersecurity thought leaders from government and industry and executives from small and edium-sized businesses (SMB) in a unique…
Read More
Lentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc.
Lentigen Technology Inc., a subsidiary of Miltenyi Biotec GmbH, announced today its acquisition of immunotherapy start-up Living Pharma, Inc. Eduardo Davila, PhD, Living Pharma…
Read More
Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab – Pharmaceutical Business Review
Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m. Raxibacumab is a fully human monoclonal antibody, which secured…
Read More
Emergent Bio buys anthrax biologic raxibacumab from Glaxo for up to $96M – Emergent BioSolutions Inc. (NYSE:EBS) | Seeking Alpha
Emergent Biosystems (NYSE:EBS) inks an agreement with GlaxoSmithKline (NYSE:GSK) to acquire raxibacumab, a fully human monoclonal antibody for the treatment and prevention of inhaled…
Read More
OpGen Announces Closing of $10 Million Public Offering – OpGen
OpGen, Inc. (NASDAQ:OPGN) announces the closing of its previously announced public offering of 18,164,195 units at $0.40 per unit, and 6,835,805 pre-funded units at…
Read More
OMNITEC WINS NIH CONTRACT – Joan Phillips-Holland – Pulse – LinkedIn
OMNITEC Solutions, Inc.’s Health Services Division will continue and expand their support of the National Institutes of Health (NIH), National Institute of Mental Health…
Read More